EX-10.139.2
from 10-K
4 pages
2nd Amendment to the Development, Licence and Supply Agreement Entered on December 18, 2007 (Hereinafter Referred to as “Agreement”) by and Between Grünenthal Gmbh Zieglerstr. 6 52078 Aachen, Germany (“Grünenthal”) and Endo Pharmaceuticals Inc. 1400 Atwater Drive Malvern, Pa 19355, USA
12/34/56
EX-10.145
from 10-Q
72 pages
Membership Interest Purchase and Sale Agreement Among Generics International (US) Inc., Boca Life Science Holdings, LLC, Boca Pharmacal, LLC and the Members of Boca Life Science Holdings, LLC Dated as of August 27, 2013 1
12/34/56
EX-10.1
from 8-K
1 page
Re: Notice of Termination of the Sales and Promotional Services Agreement by and Between Ventiv Commercial Services, LLC (“Ventiv”) and Endo Pharmaceuticals Inc. (“Endo”), Effective December 30, 2011, as Amended (“Agreement”) Dear Paul, This Letter Is to Inform Ventiv That Endo Hereby Gives Notice to Terminate the Above-Referenced Agreement in Accordance With Article XI, Section 11.2.c. the Effective Date of Said Termination Shall Be July 1, 2013. We Thank You for Your Services. Please Let Me Know if You Have Any Questions Concerning This Matter. Thank You, /S/ Brian Lortie Brian Lortie Senior Vice President CC: Inventiv Health, Inc. 500 Atrium Drive Somerset, Nj 08873 Attn: General Counsel, Commercial
12/34/56